English | Español
Robert Hadley | Apr 7, 2017

Generic arthritis medicine shown effective in clinical trial
Robert Hadley | Apr 6, 2017

FDA clears ovarian cancer drug for broad uses
Robert Hadley | Apr 6, 2017

New ALS test may speed clinical trials
Kyle Perrotti | Apr 6, 2017

Parker Institute, Cancer Research Institute join forces for project
+ Regulatory
John Breslin | Apr 6, 2017

Gottlieb to Senate committee: FDA must be a 'regulatory watchdog'
+ Regulatory
Robert Hadley | Apr 5, 2017

European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment
Erianne Leatherman | Apr 5, 2017

BMS, Foundation Medicine partner on predictive biomarker project
Robert Hadley | Apr 5, 2017

Pharma spinoff AbbVie joins network to share oncology outcomes

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes